A New Crystal Form of the SARS-CoV-2 Receptor Binding Domain: CR3022 Complex-An Ideal Target for In-Crystal Fragment Screening of the ACE2 Binding Site Surface. (2020)
Attributed to:
Mapping antibody class switch mechanisms and function
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3389/fphar.2020.615211
PubMed Identifier: 33381049
Publication URI: http://europepmc.org/abstract/MED/33381049
Type: Journal Article/Review
Volume: 11
Parent Publication: Frontiers in pharmacology
ISSN: 1663-9812